| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Sorafenib IMpurity |
索拉非尼雜質(zhì) |
1256817-30-7 |
詳細(xì)
|
| Levonorgestrel IMpurity A |
左炔諾孕酮雜質(zhì) |
|
詳細(xì)
|
| BendaMustine IMpurity |
苯達(dá)莫司汀雜質(zhì) |
|
詳細(xì)
|
| 7-epi-Obeticholic acid 3-obeticholate ester |
奧貝膽酸雜質(zhì) |
1908444-28-9 |
詳細(xì)
|
| Dronedarone HCl impurity |
鹽酸決奈達(dá)隆雜質(zhì) |
1310430-09-1 |
詳細(xì)
|
| 3-[2-[4-[4-Fluoro-2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]benzolyl]piperidin-1-yl]ethyl-2-Methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyriMidin-4-one (Risperidone IMpurity) |
利培酮雜質(zhì) |
1329796-66-8 |
詳細(xì)
|
| 2-[4-(2-Methylpropyl)phenyl] ethanol |
布洛芬雜質(zhì) |
2143535-25-3 |
詳細(xì)
|
| IndapaMide iMpurity |
吲達(dá)帕胺雜質(zhì) |
|
詳細(xì)
|
| Thioctic Acid IMpurity |
硫辛酸雜質(zhì) |
25636-58-2 |
詳細(xì)
|
| Cefalexin IMpurity ( 3-aMinoMethylene-6-phenylpiperazine-2,5-dione) |
頭孢氨芐雜質(zhì) |
65870-51-1 |
詳細(xì)
|
| LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl) |
左乙拉西坦雜質(zhì) |
1933471-30-7 |
詳細(xì)
|
| SalbutaMol IMpurity C |
沙丁胺醇雜質(zhì) |
|
詳細(xì)
|
| Canagliflozin iMpurity |
卡格列凈雜質(zhì) |
|
詳細(xì)
|
| Regorafenib iMpurity |
瑞格非尼雜質(zhì) |
1333390-56-9 |
詳細(xì)
|
| Linagliptin impurity |
利格列汀雜質(zhì) |
|
詳細(xì)
|
| Docetaxel (Docetaxel) Impurity |
多西他賽（多西紫杉醇）雜質(zhì) |
|
詳細(xì)
|
| Gefitinib iMpurity |
吉非替尼雜質(zhì) |
1608115-59-8 |
詳細(xì)
|
| Mirabegron iMpurity |
米拉貝隆雜質(zhì) |
1581285-26-8 |
詳細(xì)
|
| Dexchlorpheniramine Maleate impurity |
馬來酸氯苯那敏雜質(zhì) |
|
詳細(xì)
|
| Glimepiride impurity |
格列美脲雜質(zhì) |
|
詳細(xì)
|
| Nifuratel Impurity |
硝呋太爾雜質(zhì) |
167103-07-3 |
詳細(xì)
|
| Vinpocetine Impurity |
長春西汀雜質(zhì) |
102341-40-2 |
詳細(xì)
|
| Pregabalin Diacid |
普瑞巴林雜質(zhì) |
1788341-42-3 |
詳細(xì)
|
| Erlotinib (erlotinib) impurity |
厄洛替尼(埃羅替尼)雜質(zhì) |
|
詳細(xì)
|
| N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl Lansoprazole Sulfide |
蘭索拉唑雜質(zhì) |
1083100-27-9 |
詳細(xì)
|
| cleMastine fuMarate iMpurity |
氯馬斯汀雜質(zhì) |
|
詳細(xì)
|
| Doxofylline iMpurity |
多索茶堿雜質(zhì) |
254760-82-2 |
詳細(xì)
|
| guaifenesin iMpurity |
愈創(chuàng)甘油醚雜質(zhì) |
|
詳細(xì)
|
| EveroliMus iMpurity |
依維莫司雜質(zhì) |
1661009-29-5 |
詳細(xì)
|
| Levocarnitine iMpurity |
左卡尼汀雜質(zhì) |
6490-20-6 |
詳細(xì)
|
| Bisoprolol IMpurity |
比索洛爾雜質(zhì) |
2226263-67-6 |
詳細(xì)
|
| Sofosbuvir IMpurity |
索非布韋雜質(zhì) |
|
詳細(xì)
|
| 4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide |
樂伐替尼雜質(zhì) |
417722-93-1 |
詳細(xì)
|
| Olaparib iMpurity |
奧拉帕尼雜質(zhì) |
|
詳細(xì)
|
| Raloxifene EP IMpurity |
雷洛昔芬雜質(zhì) |
1700655-64-6 |
詳細(xì)
|
| Nicergoline Imp.(EP) |
尼麥角林雜質(zhì) |
|
詳細(xì)
|
| Valdecoxib impurity |
伐地考昔雜質(zhì) |
|
詳細(xì)
|
| Eplerenone EP impurity |
依普利酮EP雜質(zhì) |
|
詳細(xì)
|
| Blonanserin iMpurity |
布南色林雜質(zhì) |
132810-83-4 |
詳細(xì)
|
| Vardenafil IMpurity 3 |
伐地那非雜質(zhì) |
1255919-01-7 |
詳細(xì)
|
| Ezetimibe Impurity |
依折麥布雜質(zhì) |
1510820-22-0 |
詳細(xì)
|
| Clopidogrel |
氯吡格雷雜質(zhì) |
1319197-71-1 |
詳細(xì)
|
| CitalopraM IMpurity |
西酞普蘭雜質(zhì) |
|
詳細(xì)
|
| TriaMcinolone |
曲安奈德雜質(zhì) |
|
詳細(xì)
|
| Fosaprepitant Impurity 5 |
福沙吡坦雜質(zhì) |
327623-35-8 |
詳細(xì)
|
| Dexamethasone acetate impurity |
醋酸地塞米松雜質(zhì) |
|
詳細(xì)
|
| Ganciclovir and Valganciclovir Impurities |
更昔洛韋及纈更昔洛韋雜質(zhì) |
|
詳細(xì)
|
| Milrinone Impurity |
米力農(nóng)雜質(zhì) |
|
詳細(xì)
|
| Cinacalcet IMpurity |
西那卡塞雜質(zhì) |
1229224-93-4 |
詳細(xì)
|
| Vildagliptin iMpurity A-F |
維格列汀雜質(zhì) |
1846606-32-3 |
詳細(xì)
|
| Riociguat IMpurtiy |
利奧西呱雜質(zhì) |
2920299-23-4 |
詳細(xì)
|
| Tedizolid IMpurity |
特地唑胺雜質(zhì) |
1256966-04-7 |
詳細(xì)
|
| Ornidazole Impurity |
奧硝唑雜質(zhì) |
1100750-18-2 |
詳細(xì)
|
| Terbinafine |
特比萘芬雜質(zhì) |
151222-50-3 |
詳細(xì)
|
| Pabuximab impurity |
帕布昔利布雜質(zhì) |
|
詳細(xì)
|
| Cimetidine EP impurity |
西咪替丁EP雜質(zhì) |
|
詳細(xì)
|
| Levothyroxine sodium impurity |
左旋甲狀腺素鈉雜質(zhì) |
|
詳細(xì)
|
| Pemetrexed disodium EP impurity |
培美曲塞二鈉EP雜質(zhì) |
|
詳細(xì)
|
| Celecoxib Impurity 2 |
塞來昔布雜質(zhì) |
948293-46-7 |
詳細(xì)
|
| 2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-propanol |
孟魯司特鈉雜質(zhì) |
287930-77-2 |
詳細(xì)
|
| (2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyriMidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) |
伏立康唑雜質(zhì) |
|
詳細(xì)
|
| Pioglitazone BroMo IMpurity |
吡格列酮雜質(zhì) |
|
詳細(xì)
|
| (S)-N-(1-AMino-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
硼替佐米雜質(zhì) |
289472-80-6 |
詳細(xì)
|
| Lurasidon hydrochloride iMpurity |
魯拉西酮雜質(zhì) |
1260138-03-1 |
詳細(xì)
|
| Minocycline hrdrochloride iMpurity |
米諾環(huán)素雜質(zhì) |
|
詳細(xì)
|
| Irbesartan IMpurity |
厄貝沙坦雜質(zhì) |
1079997-01-5 |
詳細(xì)
|
| Ibrutinib iMpurity |
依魯替尼雜質(zhì) |
936351-48-3 |
詳細(xì)
|
| Neratinib Impurity |
來那替尼雜質(zhì) |
1348481-03-7 |
詳細(xì)
|
| Luliconazole impurity |
盧立康唑雜質(zhì) |
|
詳細(xì)
|
| Mosapride IMP |
莫沙必利雜質(zhì) |
|
詳細(xì)
|
| Neptidine impurity |
奈妥吡坦雜質(zhì) |
|
詳細(xì)
|
| 2-Desisopropyl-2-phenyl Repaglinide |
瑞格列奈雜質(zhì) |
107362-12-9 |
詳細(xì)
|
| Salicylic Acid Impurity 46 |
水楊酸雜質(zhì) |
1172605-63-8 |
詳細(xì)
|
| 3-(1,2-Benzisothiazolyl) Ziprasidone
(Ziprasidone Impurity E) |
齊拉西酮雜質(zhì) |
1159977-04-4 |
詳細(xì)
|
| CV 15959 |
坎地沙坦酯雜質(zhì) |
168434-02-4 |
詳細(xì)
|
| 1-cyclopropyl-6-fluoro-1,4-dihydro-7-((4aR,7aS)-octahydropyrrolo [3,4-b]pyridin-6-yl)-8-Methoxy-4-oxoquinoline-3-carboxylic acid |
莫西沙星雜質(zhì) |
1394029-14-1 |
詳細(xì)
|
| (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile |
托法替尼雜質(zhì) |
1640971-60-3 |
詳細(xì)
|
| Budesonide iMpurity |
布地奈德雜質(zhì) |
192057-49-1 |
詳細(xì)
|
| Retigabine Dihydrochloride Impurity |
瑞替加濱雜質(zhì) |
1432063-93-8 |
詳細(xì)
|
| Dapoxetine iMpurity |
達(dá)泊西汀雜質(zhì) |
94305-25-6 |
詳細(xì)
|
| Pabuxilibu impurities |
帕布昔利布雜質(zhì) |
|
詳細(xì)
|
| Dipyridamole Impurity Reference |
雙嘧達(dá)莫雜質(zhì)對照品 |
|
詳細(xì)
|
| Ticagrelor iMpurity |
替卡格雷雜質(zhì) |
1882095-51-3 |
詳細(xì)
|
| Rabeprazole iMpurity (Chloro interMediate) |
雷貝拉唑雜質(zhì) |
|
詳細(xì)
|
| Entecavir Impurity |
恩替卡韋雜質(zhì) |
1333204-94-6 |
詳細(xì)
|
| Nicorandil Impurity |
尼可地爾雜質(zhì) |
|
詳細(xì)
|
| 5,10-Dihydro-2-methyl- |
奧氮平雜質(zhì) |
612507-13-8 |
詳細(xì)
|
| (S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone |
匹多莫德雜質(zhì) |
14842-41-2 |
詳細(xì)
|
| N,O-DESETHYLENE LINEZOLID |
利奈唑胺雜質(zhì) |
1219708-30-1 |
詳細(xì)
|
| Sitagliptin IMpurity |
西格列汀雜質(zhì) |
1675201-14-5 |
詳細(xì)
|
| levocetirizine IMpurity |
左西替利嗪雜質(zhì) |
|
詳細(xì)
|
| Norepinephrine IMpurity (2-AMino-1-(3,4-dihydroxyphenyl)ethan-1-one HCl) |
去甲腎上腺素雜質(zhì) |
|
詳細(xì)
|
| AlviMopan iMpurity |
愛維莫潘雜質(zhì) |
|
詳細(xì)
|
| Saxagliptin iMpurity |
沙格列汀雜質(zhì) |
2173146-35-3 |
詳細(xì)
|
| IMatinib iMpurity |
伊馬替尼雜質(zhì) |
152459-96-6 |
詳細(xì)
|
| Intedanib Impurity |
尼達(dá)尼布雜質(zhì) |
2243396-74-7 |
詳細(xì)
|
| Erythromycin Impurity |
紅霉素雜質(zhì) |
40554-78-7 |
詳細(xì)
|
| Tirofiban hydrochloride impurities |
鹽酸替羅非班雜質(zhì) |
|
詳細(xì)
|
| Calcipotriol EP impurities |
卡泊三醇EP雜質(zhì) |
|
詳細(xì)
|
| Pramipexole Impurity Reference |
普拉克索雜質(zhì)對照品 |
|
詳細(xì)
|